Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3228127
Max Phase: Preclinical
Molecular Formula: C20H40N4O11
Molecular Weight: 512.56
Molecule Type: Small molecule
Associated Items:
ID: ALA3228127
Max Phase: Preclinical
Molecular Formula: C20H40N4O11
Molecular Weight: 512.56
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CNC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](NC)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C20H40N4O11/c1-23-4-8-12(27)14(29)15(30)20(32-8)35-18-7(22)3-6(21)17(16(18)31)34-19-13(28)10(24-2)11(26)9(5-25)33-19/h6-20,23-31H,3-5,21-22H2,1-2H3/t6-,7+,8-,9-,10+,11-,12-,13-,14+,15-,16-,17+,18-,19-,20-/m1/s1
Standard InChI Key: HWYDLBNHNFOTKQ-ODWRYJTKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 512.56 | Molecular Weight (Monoisotopic): 512.2694 | AlogP: -6.77 | #Rotatable Bonds: 8 |
Polar Surface Area: 254.63 | Molecular Species: BASE | HBA: 15 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.05 | CX Basic pKa: 9.52 | CX LogP: -6.20 | CX LogD: -11.56 |
Aromatic Rings: 0 | Heavy Atoms: 35 | QED Weighted: 0.14 | Np Likeness Score: 1.61 |
1. Kumar V, Remers WA.. (1979) Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins., 22 (4): [PMID:107311] [10.1021/jm00190a015] |
Source(1):